Table 2.
MCO | TDH | |||
Male | Female | Male | Female | |
n (%) | n (%) | n (%) | n (%) | |
LD | 372 (44.1%) | 531 (58.8%) | 124 (42.5%) | 168 (57.5%) |
RMSF | 348 (52.6%) | 313 (47.4%) | 783 (56.6%) | 601 (43.4%) |
HME | 7 (50.0%) | 7 (50.0%) | 238 (68.4%) | 110 (31.6%) |
Tularemia | 26 (61.9%) | 16 (38.1%) | 23 (79.3%) | 6 (20.7%) |
LACV | 9 (90.0%) | 1 (10.0%) | 39 (65.0%) | 21 (35.0%) |
WNV | 10 (47.6%) | 11 (52.4%) | 31 (67.4%) | 15 (32.6%) |
Totals* | 772 (46.8%) | 779 (53.2%) | 1238 (57.3%) | 921 (42.7%) |
6 TDH cases had unknown gender.
HME, human monocytic ehrlichiosis; LACV, La Crosse viral encephalitis; LD, Lyme disease; MCO, managed care organization; TDH; Tennessee Department of Health; RMSF, Rocky Mountain spotted fever; WNV, West Nile virus.